Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives

Non-Hodgkin lymphoma (NHL) is a heterogeneous malignancy with variable patient outcomes. There is still a lack of understanding about the different players involved in lymphomagenesis, and the identification of new diagnostic and prognostic biomarkers is urgent. MicroRNAs and long non-coding RNAs em...

Full description

Saved in:
Bibliographic Details
Published inBiomedicines Vol. 9; no. 12; p. 1934
Main Authors Fernandes, Mara, Marques, Herlander, Teixeira, Ana Luísa, Medeiros, Rui
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 17.12.2021
MDPI
Subjects
B-cell lymphoma
Biomarkers
Biopsy
Cell cycle
Cell growth
Chemotherapy
Gene expression
lncRNAs
Lymphocytes B
Lymphoma
Malignancy
Medical prognosis
MicroRNAs
miRNA
miRNAs
Molecular modelling
Non-coding RNA
Non-Hodgkin's lymphoma
Pathogenesis
Patients
Review
Transcription factors
lncRNAs
non-Hodgkin’s lymphoma
miRNAs
biomarkers
lymphoma
Online AccessGet full text

Cover

Abstract Non-Hodgkin lymphoma (NHL) is a heterogeneous malignancy with variable patient outcomes. There is still a lack of understanding about the different players involved in lymphomagenesis, and the identification of new diagnostic and prognostic biomarkers is urgent. MicroRNAs and long non-coding RNAs emerged as master regulators of B-cell development, and their deregulation has been associated with the initiation and progression of lymphomagenesis. They can function by acting alone or, as recently proposed, by creating competing endogenous RNA (ceRNA) networks. Most studies have focused on individual miRNAs/lncRNAs function in lymphoma, and there is still limited data regarding their interactions in lymphoma progression. The study of miRNAs' and lncRNAs' deregulation in NHL, either alone or as ceRNAs networks, offers new insights into the molecular mechanisms underlying lymphoma pathogenesis and opens a window of opportunity to identify potential diagnostic and prognostic biomarkers. In this review, we summarized the current knowledge regarding the role of miRNAs and lncRNAs in B-cell lymphoma, including their interactions and regulatory networks. Finally, we summarized the studies investigating the potential of miRNAs and lncRNAs as clinical biomarkers, with a special focus on the circulating profiles, to be applied as a non-invasive, easy-to-obtain, and reproducible liquid biopsy for dynamic management of NHL patients.
AbstractList Non-Hodgkin lymphoma (NHL) is a heterogeneous malignancy with variable patient outcomes. There is still a lack of understanding about the different players involved in lymphomagenesis, and the identification of new diagnostic and prognostic biomarkers is urgent. MicroRNAs and long non-coding RNAs emerged as master regulators of B-cell development, and their deregulation has been associated with the initiation and progression of lymphomagenesis. They can function by acting alone or, as recently proposed, by creating competing endogenous RNA (ceRNA) networks. Most studies have focused on individual miRNAs/lncRNAs function in lymphoma, and there is still limited data regarding their interactions in lymphoma progression. The study of miRNAs’ and lncRNAs’ deregulation in NHL, either alone or as ceRNAs networks, offers new insights into the molecular mechanisms underlying lymphoma pathogenesis and opens a window of opportunity to identify potential diagnostic and prognostic biomarkers. In this review, we summarized the current knowledge regarding the role of miRNAs and lncRNAs in B-cell lymphoma, including their interactions and regulatory networks. Finally, we summarized the studies investigating the potential of miRNAs and lncRNAs as clinical biomarkers, with a special focus on the circulating profiles, to be applied as a non-invasive, easy-to-obtain, and reproducible liquid biopsy for dynamic management of NHL patients.
Author Fernandes, Mara
Marques, Herlander
Teixeira, Ana Luísa
Medeiros, Rui
AuthorAffiliation 4 Life and Health Sciences Research Institute (ICVS), School of Medicine, Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal; herlandermarques@hotmail.com
1 Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal; mara.aires.fernandes@ipoporto.min-saude.pt (M.F.); ana.luisa.teixeira@ipoporto.min-saude.pt (A.L.T.)
7 CINTESIS, Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal
3 Faculty of Medicine, University of Porto (FMUP), 4200-319 Porto, Portugal
6 Department of Oncology, Hospital de Braga, 4710-243 Braga, Portugal
9 Biomedical Research Center (CEBIMED), Faculty of Health Sciences of Fernando Pessoa University (UFP), 4249-004 Porto, Portugal
2 Research Department of the Portuguese League against Cancer Regional Nucleus
AuthorAffiliation_xml – name: 6 Department of Oncology, Hospital de Braga, 4710-243 Braga, Portugal
– name: 9 Biomedical Research Center (CEBIMED), Faculty of Health Sciences of Fernando Pessoa University (UFP), 4249-004 Porto, Portugal
– name: 7 CINTESIS, Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal
– name: 3 Faculty of Medicine, University of Porto (FMUP), 4200-319 Porto, Portugal
– name: 1 Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal; mara.aires.fernandes@ipoporto.min-saude.pt (M.F.); ana.luisa.teixeira@ipoporto.min-saude.pt (A.L.T.)
– name: 8 ICBAS—Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-513 Porto, Portugal
– name: 4 Life and Health Sciences Research Institute (ICVS), School of Medicine, Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal; herlandermarques@hotmail.com
– name: 2 Research Department of the Portuguese League against Cancer Regional Nucleus of the North (LPCC-NRN), 4200-177 Porto, Portugal
– name: 5 ICVS/3B’s–PT Government Associate Laboratory, 4805-017 Braga/Guimarães, Portugal
Author_xml – sequence: 1
  givenname: Mara
  orcidid: 0000-0001-9023-1109
  surname: Fernandes
  fullname: Fernandes, Mara
  email: RISE@CI-IPOP
  organization: Faculty of Medicine, University of Porto (FMUP), 4200-319 Porto, Portugal
– sequence: 2
  givenname: Herlander
  orcidid: 0000-0002-5854-4444
  surname: Marques
  fullname: Marques, Herlander
  organization: CINTESIS, Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal
– sequence: 3
  givenname: Ana Luísa
  orcidid: 0000-0002-7489-2211
  surname: Teixeira
  fullname: Teixeira, Ana Luísa
  email: RISE@CI-IPOP
  organization: ICBAS-Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-513 Porto, Portugal
– sequence: 4
  givenname: Rui
  orcidid: 0000-0003-3010-8373
  surname: Medeiros
  fullname: Medeiros, Rui
  email: RISE@CI-IPOP
  organization: Biomedical Research Center (CEBIMED), Faculty of Health Sciences of Fernando Pessoa University (UFP), 4249-004 Porto, Portugal
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34944752$$D View this record in MEDLINE/PubMed
BookMark eNptUk1v1DAQjVARLaW_AAlF4tLLgr-S2ByQVlGhK622CMHZcuxJ6m1iBzu7qEf-OU63VC2qLx6N3zzPvHmvsyPnHWTZW4w-UCrQx8b6AYzV1kEUmGBB2YvshBBSLQQqxNGj-Dg7i3GL0hGYcsxeZceUCcaqgpxkf2o_jDDZye4hv3DGd-D8LubfN8t8A9NvH27yldv7fm9dlw92zitn8t7pObQu33i3uPSmu0nx-nYYr_2gPuX1LgRwU740e-U0xLuiurfOatXn3yDEEfT8aXyTvWxVH-Hs_j7Nfn65-FFfLtZXX1f1cr3QTIhpYajR0DJWlsRwg4uKFKCUZpVpWCtEUyhETdlQCgVqm4pjRUSSgKIW4RJxTk-z1YHXeLWVY7CDCrfSKyvvEj50UoXJ6h5kYVirjeBMAWPG8EQtaIXbJDRrDWOJ6_OBa9w1aQ06TRpU_4T06Yuz17Lze8lLwTkrEsH5PUHwv3YQJznYqKHvlYMkvyQlZoRWCM19v_8PuvW74JJUM4qkLfJqRtEDSgcfY4D2oRmM5OwY-YxjUtW7x3M81PzzB_0LwkXCVQ
CitedBy_id crossref_primary_10_1515_med_2023_0666
Cites_doi 10.1038/s41417-020-00267-4
10.12659/MSM.912141
10.2147/OTT.S249429
10.1038/bcj.2012.1
10.1016/j.cell.2007.07.021
10.1073/pnas.1208398109
10.1073/pnas.1019055108
10.1126/science.1141229
10.2147/CMAR.S248698
10.1186/s12935-020-1158-6
10.1089/nat.2012.0343
10.1159/000346441
10.1038/ni.3299
10.1182/blood-2013-12-543611
10.1016/j.exphem.2015.12.007
10.1016/S0140-6736(16)32407-2
10.1016/j.ajpath.2012.03.013
10.1097/MD.0000000000007952
10.1038/s41419-019-1479-3
10.1016/j.urolonc.2012.05.012
10.3892/mmr.2016.5190
10.1016/j.lfs.2021.119932
10.1101/gad.1654808
10.1371/journal.pone.0170521
10.1007/s00277-014-2271-1
10.1016/j.biopha.2015.12.001
10.1016/j.bbamcr.2013.10.016
10.1007/s00277-011-1350-9
10.3727/096504017X14886679715637
10.12659/MSM.922810
10.3390/ncrna7010001
10.1038/s41598-020-66062-1
10.1182/blood-2018-01-824540
10.2147/CMAR.S233859
10.3892/or.2020.7897
10.1371/journal.pone.0016408
10.1182/blood-2010-10-312231
10.3389/fmolb.2017.00038
10.3892/ol.2015.3866
10.1186/s12935-021-01992-y
10.1007/978-1-4939-3378-5
10.1038/leu.2015.119
10.1016/j.cell.2011.07.014
10.18632/oncotarget.6165
10.1001/jama.2010.1919
10.1186/s12943-016-0524-4
10.1111/jcmm.14601
10.1111/ejh.12263
10.4132/jptm.2016.06.06
10.1016/S0092-8674(04)00045-5
10.1002/gcc.1187
10.1101/gad.1872909
10.1016/j.yexmp.2020.104451
10.1155/2016/9085195
10.1038/nature09284
10.1007/s00277-016-2840-6
10.3389/fendo.2018.00402
10.1073/pnas.1213764109
10.2147/CMAR.S284258
10.1093/carcin/bgab013
10.1016/j.omtn.2019.09.005
10.1182/blood-2017-03-769620
10.1158/1078-0432.CCR-10-3244
10.1016/j.cell.2014.05.049
10.1016/j.cca.2014.02.010
10.3390/cells8091015
10.1093/intimm/dxq042
10.1007/s10238-015-0350-9
10.1038/leu.2014.126
10.1016/j.tips.2019.01.006
10.1016/j.lfs.2019.03.040
10.1038/s41419-019-1886-5
10.1073/pnas.0910667107
10.1038/nature03552
10.1038/srep27842
10.18632/oncotarget.26141
10.3233/CBM-160221
10.1177/1179299X18781095
10.3390/ncrna5010017
10.1073/pnas.0702409104
10.1111/j.1365-2141.2008.07077.x
10.1016/j.immuni.2007.10.009
10.1016/j.biopha.2016.02.032
10.1038/s41598-021-81715-5
10.3389/fmed.2020.612393
10.1016/j.clml.2014.02.011
10.3892/or.2017.5821
10.1111/jcmm.13667
10.1182/blood-2008-09-178186
10.4049/jimmunol.2001039
10.1038/ni1575
10.1038/emboj.2013.178
10.1126/science.288.5470.1439
10.1371/journal.pone.0138236
10.18632/oncotarget.20053
10.1016/j.ncrna.2020.10.001
10.1111/bjh.15656
10.1007/s00277-014-2111-3
10.1186/s13046-018-0768-5
10.1002/(SICI)1098-2264(199804)21:4<298::AID-GCC3>3.0.CO;2-U
10.1016/j.bbrc.2019.01.105
10.1182/blood.V92.1.234.413k22_234_240
10.1084/jem.20140338
10.1016/j.gene.2015.11.029
10.3390/cells9020276
10.1016/j.ajpath.2016.05.011
10.3390/cells10010048
10.1007/s00277-015-2553-2
10.1016/j.ccell.2016.03.010
10.2147/CMAR.S299715
10.1002/cbin.11327
10.1182/blood.V124.21.2988.2988
10.1101/gr.132159.111
10.1016/j.cell.2015.02.043
10.1016/j.critrevonc.2019.102825
10.1186/s12943-017-0580-4
10.1016/j.biopha.2017.02.011
10.1038/s41598-019-52985-x
10.1016/j.gene.2017.11.022
10.1002/emmm.200900028
10.1371/journal.pgen.1007050
10.3390/ijms21062081
10.1038/nrg3606
10.1080/10428194.2021.1876866
10.1038/onc.2011.470
10.1016/j.cell.2018.01.011
10.1007/s12185-012-1256-x
10.1073/pnas.0506654102
10.1007/s10238-015-0396-8
10.1186/s11658-019-0175-8
10.1038/leu.2011.166
10.1038/leu.2013.298
10.1007/s11010-019-03588-7
10.3389/fonc.2021.650287
10.1186/s13073-015-0230-7
10.1016/j.celrep.2016.05.084
10.1016/j.leukres.2018.05.006
10.1002/1878-0261.12834
10.1016/j.prp.2018.08.006
10.1182/blood-2018-06-855502
10.1186/s12967-016-1100-9
10.1371/journal.pone.0187722
10.1016/j.bbrc.2017.08.070
10.1073/pnas.242606799
10.18632/oncotarget.16163
10.1182/blood-2011-06-361972
ContentType Journal Article
Copyright 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 by the authors. 2021
Copyright_xml – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 by the authors. 2021
DBID NPM
AAYXX
CITATION
8FE
8FH
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
HCIFZ
LK8
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.3390/biomedicines9121934
DatabaseName PubMed
CrossRef
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
ProQuest Central Student
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
Biological Sciences
Biological Science Database
ProQuest - Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Biological Science Collection
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Biological Science Database
ProQuest SciTech Collection
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest One Academic
MEDLINE - Academic
DatabaseTitleList CrossRef
Publicly Available Content Database

MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 2227-9059
ExternalDocumentID oai_doaj_org_article_5d4fcd984ae44dd8a039371f9124fd44
10_3390_biomedicines9121934
34944752
Genre Journal Article
Review
GroupedDBID 53G
5VS
8FE
8FH
AADQD
AAFWJ
ACPRK
ADBBV
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BBNVY
BCNDV
BENPR
BHPHI
CCPQU
EMOBN
GROUPED_DOAJ
GX1
HCIFZ
HYE
IAO
IHR
INH
ITC
KQ8
LK8
M7P
MODMG
M~E
NPM
OK1
PGMZT
PIMPY
PROAC
RPM
AAYXX
CITATION
ABUWG
AZQEC
DWQXO
GNUQQ
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c499t-d3dcef44662d8d15725eaac47db4f99b5a03d6b33e50fb781a2922230f0160883
IEDL.DBID RPM
ISSN 2227-9059
IngestDate Tue Oct 22 15:08:11 EDT 2024
Tue Sep 17 21:06:53 EDT 2024
Sat Oct 26 05:47:13 EDT 2024
Sat Nov 09 13:23:58 EST 2024
Thu Sep 26 21:12:26 EDT 2024
Sat Nov 02 12:30:32 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords lncRNAs
non-Hodgkin’s lymphoma
miRNAs
biomarkers
lymphoma
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c499t-d3dcef44662d8d15725eaac47db4f99b5a03d6b33e50fb781a2922230f0160883
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ORCID 0000-0002-5854-4444
0000-0003-3010-8373
0000-0001-9023-1109
0000-0002-7489-2211
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698845/
PMID 34944752
PQID 2612752878
PQPubID 2032426
ParticipantIDs doaj_primary_oai_doaj_org_article_5d4fcd984ae44dd8a039371f9124fd44
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8698845
proquest_miscellaneous_2614237008
proquest_journals_2612752878
crossref_primary_10_3390_biomedicines9121934
pubmed_primary_34944752
PublicationCentury 2000
PublicationDate 20211217
PublicationDateYYYYMMDD 2021-12-17
PublicationDate_xml – month: 12
  year: 2021
  text: 20211217
  day: 17
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Biomedicines
PublicationTitleAlternate Biomedicines
PublicationYear 2021
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References ref_94
Adams (ref_151) 2016; 95
Gururajan (ref_42) 2010; 22
Ebralidze (ref_72) 2008; 22
Bartel (ref_7) 2004; 116
Bai (ref_50) 2013; 97
Guo (ref_156) 2020; 12
Mu (ref_30) 2009; 23
ref_14
Peng (ref_128) 2016; 16
ref_10
ref_97
Si (ref_17) 2019; 24
Cimmino (ref_57) 2005; 102
Chen (ref_118) 2014; 92
Wang (ref_75) 2017; 8
Cui (ref_101) 2021; 21
Craig (ref_53) 2011; 117
Isin (ref_141) 2014; 431
Qi (ref_147) 2016; 15
Pal (ref_165) 2013; 31
ref_15
Song (ref_122) 2014; 93
Yuan (ref_124) 2016; 11
Qian (ref_163) 2020; 7
Neat (ref_25) 2001; 32
Pan (ref_137) 2016; 577
Sandhu (ref_39) 2012; 109
Tian (ref_90) 2021; 25
Johnson (ref_65) 2016; 128
Torkamani (ref_70) 2012; 109
Wang (ref_83) 2016; 14
ref_123
Li (ref_84) 2017; 89
Zhang (ref_139) 2019; 25
Trimarchi (ref_85) 2014; 158
Verma (ref_146) 2015; 7
Liao (ref_20) 2019; 18
Ahmadvand (ref_113) 2018; 70
Medina (ref_47) 2010; 467
Zauli (ref_52) 2011; 17
Fu (ref_96) 2021; 13
Blume (ref_74) 2015; 29
Florian (ref_87) 2015; 161
Xiao (ref_29) 2008; 9
Vigorito (ref_34) 2007; 27
Cui (ref_119) 2018; 9
Meng (ref_68) 2017; 25
ref_159
ref_71
Mollejo (ref_145) 2012; 2
ref_158
Marchesi (ref_121) 2018; 37
Fatica (ref_21) 2014; 15
Lawrie (ref_110) 2008; 141
Rao (ref_27) 1998; 92
Thai (ref_35) 2007; 316
Zhou (ref_131) 2017; 16
Mur (ref_51) 2014; 124
Zhao (ref_132) 2017; 8
ref_154
Derrien (ref_13) 2012; 22
ref_157
Sehgal (ref_82) 2014; 28
Hayder (ref_6) 2018; 9
Zhang (ref_45) 2009; 113
Huang (ref_95) 2021; 42
ref_160
Rovira (ref_3) 2015; 94
Zhou (ref_61) 2007; 104
Salmena (ref_16) 2011; 146
Rizzo (ref_54) 2012; 22
Williams (ref_155) 2014; 14
Pedersen (ref_40) 2009; 1
Huang (ref_36) 2012; 181
ref_148
Gao (ref_130) 2017; 38
Paulsen (ref_126) 2020; 10
ref_142
Rai (ref_41) 2010; 107
Beheshti (ref_116) 2019; 9
Roisman (ref_138) 2019; 184
Spierings (ref_23) 2011; 117
Villela (ref_153) 2020; 5
Yan (ref_80) 2016; 13
Zhang (ref_33) 2012; 120
DeKoter (ref_73) 2000; 288
Bouvy (ref_152) 2018; 10
Meng (ref_129) 2020; 115
Sun (ref_114) 2021; 15
Dousti (ref_134) 2018; 214
He (ref_28) 2005; 435
Shi (ref_109) 2016; 2016
Musilova (ref_62) 2018; 132
Sun (ref_136) 2016; 6
Fernandes (ref_9) 2019; 144
Tao (ref_93) 2021; 45
Lu (ref_32) 2014; 211
Tang (ref_140) 2020; 12
Zhu (ref_105) 2019; 23
Inada (ref_115) 2014; 124
Ellis (ref_69) 2014; 1843
Filip (ref_127) 2017; 96
Crump (ref_4) 2017; 130
Cheng (ref_79) 2019; 461
Wang (ref_92) 2019; 231
Shi (ref_77) 2019; 510
Zeng (ref_99) 2021; 13
Fu (ref_18) 2017; 492
Benhamou (ref_24) 2016; 16
Schell (ref_46) 2021; 206
Peng (ref_150) 2017; 17
Armitage (ref_1) 2017; 390
Kopp (ref_12) 2018; 172
Song (ref_78) 2020; 44
ref_162
Song (ref_48) 2017; 96
Leich (ref_143) 2011; 118
ref_161
ref_164
ref_66
ref_166
Fabbri (ref_58) 2011; 305
Arroyo (ref_108) 2011; 108
Xiao (ref_60) 2007; 131
Casero (ref_67) 2015; 16
Boysen (ref_56) 2014; 28
Kluiver (ref_38) 2016; 7
Zhao (ref_89) 2020; 26
Li (ref_43) 2018; 131
Fang (ref_111) 2012; 91
Bedewy (ref_112) 2017; 34
Huang (ref_63) 2019; 41
Zhang (ref_59) 2012; 31
ref_117
Chen (ref_102) 2020; 13
Zhao (ref_103) 2019; 10
Deng (ref_133) 2018; 23
Bebawy (ref_107) 2019; 40
Li (ref_120) 2015; 8
Meng (ref_125) 2018; 642
Peng (ref_76) 2016; 79
Peng (ref_86) 2016; 77
Gebauer (ref_144) 2014; 34
Jin (ref_31) 2013; 32
Zhu (ref_37) 2016; 24
Zhao (ref_100) 2019; 10
Xiong (ref_19) 2018; 22
Yu (ref_106) 2021; 11
Tayari (ref_64) 2016; 186
Li (ref_98) 2021; 2021
ref_104
Fan (ref_149) 2019; 18
Qian (ref_88) 2020; 20
Monni (ref_26) 1998; 21
ref_2
Greene (ref_22) 2017; 4
Calin (ref_5) 2002; 99
Enomoto (ref_44) 2011; 25
Zhang (ref_91) 2021; 21
Gu (ref_49) 2013; 130
Schmitt (ref_11) 2016; 29
ref_8
Marques (ref_55) 2016; 44
Oh (ref_81) 2016; 50
Senousy (ref_135) 2021; 11
References_xml – ident: ref_94
  doi: 10.1038/s41417-020-00267-4
– volume: 25
  start-page: 365
  year: 2019
  ident: ref_139
  article-title: LINK-A lncRNA Promotes Proliferation and Inhibits Apoptosis of Mantle Cell Lymphoma Cell by Upregulating Survivin
  publication-title: Med. Sci. Monit.
  doi: 10.12659/MSM.912141
  contributor:
    fullname: Zhang
– volume: 13
  start-page: 5563
  year: 2020
  ident: ref_102
  article-title: Long Noncoding RNA SNHG12 Indicates the Prognosis and Accelerates Tumorigenesis of Diffuse Large B-Cell Lymphoma Through Sponging microR-195
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S249429
  contributor:
    fullname: Chen
– volume: 2
  start-page: e57
  year: 2012
  ident: ref_145
  article-title: MicroRNA signatures in B-cell lymphomas
  publication-title: Blood Cancer J.
  doi: 10.1038/bcj.2012.1
  contributor:
    fullname: Mollejo
– volume: 117
  start-page: 5340
  year: 2011
  ident: ref_23
  article-title: Ordered progression of stage-specific miRNA profiles in the mouse B2 B-cell lineage
  publication-title: Blood J. Am. Soc. Hematol.
  contributor:
    fullname: Spierings
– volume: 131
  start-page: 146
  year: 2007
  ident: ref_60
  article-title: MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb
  publication-title: Cell
  doi: 10.1016/j.cell.2007.07.021
  contributor:
    fullname: Xiao
– volume: 109
  start-page: 17004
  year: 2012
  ident: ref_70
  article-title: Noncoding transcription within the Igh distal VH region at PAIR elements affects the 3D structure of the Igh locus in pro-B cells
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1208398109
  contributor:
    fullname: Torkamani
– volume: 108
  start-page: 5003
  year: 2011
  ident: ref_108
  article-title: Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1019055108
  contributor:
    fullname: Arroyo
– volume: 316
  start-page: 604
  year: 2007
  ident: ref_35
  article-title: Regulation of the Germinal Center Response by MicroRNA-155
  publication-title: Science
  doi: 10.1126/science.1141229
  contributor:
    fullname: Thai
– volume: 12
  start-page: 5845
  year: 2020
  ident: ref_156
  article-title: Knockdown of lncRNA MCM3AP-AS1 Attenuates Chemoresistance of Burkitt Lymphoma to Doxorubicin Treatment via Targeting the miR-15a/EIF4E Axis
  publication-title: Cancer Manag. Res.
  doi: 10.2147/CMAR.S248698
  contributor:
    fullname: Guo
– volume: 20
  start-page: 87
  year: 2020
  ident: ref_88
  article-title: MYC-regulated lncRNA NEAT1 promotes B cell proliferation and lymphomagenesis via the miR-34b-5p-GLI1 pathway in diffuse large B-cell lymphoma
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-020-1158-6
  contributor:
    fullname: Qian
– ident: ref_161
– volume: 22
  start-page: 283
  year: 2012
  ident: ref_54
  article-title: The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation
  publication-title: Nucleic Acid Ther.
  doi: 10.1089/nat.2012.0343
  contributor:
    fullname: Rizzo
– volume: 21
  start-page: 39
  year: 2021
  ident: ref_91
  article-title: Knockdown of UCA1 restrains cell proliferation and metastasis of diffuse large B-cell lymphoma by counteracting miR-331-3p expression
  publication-title: Oncol. Lett.
  contributor:
    fullname: Zhang
– volume: 130
  start-page: 87
  year: 2013
  ident: ref_49
  article-title: Inhibition of miR-21 Induces Biological and Behavioral Alterations in Diffuse Large B-Cell Lymphoma
  publication-title: Acta Haematol.
  doi: 10.1159/000346441
  contributor:
    fullname: Gu
– ident: ref_166
– volume: 16
  start-page: 1282
  year: 2015
  ident: ref_67
  article-title: Long non-coding RNA profiling of human lymphoid progenitor cells reveals transcriptional divergence of B cell and T cell lineages
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3299
  contributor:
    fullname: Casero
– volume: 124
  start-page: 229
  year: 2014
  ident: ref_51
  article-title: miR-217 is an oncogene that enhances the germinal center reaction
  publication-title: Blood
  doi: 10.1182/blood-2013-12-543611
  contributor:
    fullname: Mur
– volume: 44
  start-page: 238
  year: 2016
  ident: ref_55
  article-title: High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma
  publication-title: Exp. Hematol.
  doi: 10.1016/j.exphem.2015.12.007
  contributor:
    fullname: Marques
– volume: 390
  start-page: 298
  year: 2017
  ident: ref_1
  article-title: Non-Hodgkin lymphoma
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)32407-2
  contributor:
    fullname: Armitage
– volume: 181
  start-page: 26
  year: 2012
  ident: ref_36
  article-title: Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma
  publication-title: Am. J. Pathol.
  doi: 10.1016/j.ajpath.2012.03.013
  contributor:
    fullname: Huang
– volume: 96
  start-page: e7952
  year: 2017
  ident: ref_48
  article-title: Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma
  publication-title: Medicine
  doi: 10.1097/MD.0000000000007952
  contributor:
    fullname: Song
– volume: 10
  start-page: 252
  year: 2019
  ident: ref_100
  article-title: Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-019-1479-3
  contributor:
    fullname: Zhao
– volume: 31
  start-page: 1408
  year: 2013
  ident: ref_165
  article-title: Defining prostate cancer risk before prostate biopsy
  publication-title: Urol. Oncol.
  doi: 10.1016/j.urolonc.2012.05.012
  contributor:
    fullname: Pal
– volume: 13
  start-page: 5125
  year: 2016
  ident: ref_80
  article-title: Elevated RNA expression of long non-coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr.2016.5190
  contributor:
    fullname: Yan
– ident: ref_97
  doi: 10.1016/j.lfs.2021.119932
– volume: 34
  start-page: 207
  year: 2017
  ident: ref_112
  article-title: Prognostic Value of miRNA-155 Expression in B-Cell Non-Hodgkin Lymphoma
  publication-title: Turk. J. Haematol.
  contributor:
    fullname: Bedewy
– volume: 22
  start-page: 2085
  year: 2008
  ident: ref_72
  article-title: PU.1 expression is modulated by the balance of functional sense and antisense RNAs regulated by a shared cis-regulatory element
  publication-title: Genes Dev.
  doi: 10.1101/gad.1654808
  contributor:
    fullname: Ebralidze
– ident: ref_142
  doi: 10.1371/journal.pone.0170521
– volume: 94
  start-page: 803
  year: 2015
  ident: ref_3
  article-title: Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy
  publication-title: Ann. Hematol.
  doi: 10.1007/s00277-014-2271-1
  contributor:
    fullname: Rovira
– volume: 77
  start-page: 65
  year: 2016
  ident: ref_86
  article-title: Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B-cell lymphoma
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2015.12.001
  contributor:
    fullname: Peng
– volume: 1843
  start-page: 372
  year: 2014
  ident: ref_69
  article-title: CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism
  publication-title: Biochim. Biophys. Acta Mol. Cell Res.
  doi: 10.1016/j.bbamcr.2013.10.016
  contributor:
    fullname: Ellis
– volume: 91
  start-page: 553
  year: 2012
  ident: ref_111
  article-title: Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma
  publication-title: Ann. Hematol.
  doi: 10.1007/s00277-011-1350-9
  contributor:
    fullname: Fang
– volume: 8
  start-page: 15019
  year: 2015
  ident: ref_120
  article-title: miR-21 expression predicts prognosis in diffuse large B-cell lymphoma
  publication-title: Int. J. Clin. Exp. Pathol.
  contributor:
    fullname: Li
– volume: 25
  start-page: 1207
  year: 2017
  ident: ref_68
  article-title: Long Noncoding RNA CRNDE Promotes Multiple Myeloma Cell Growth by Suppressing miR-451
  publication-title: Oncol. Res.
  doi: 10.3727/096504017X14886679715637
  contributor:
    fullname: Meng
– volume: 26
  start-page: e922810
  year: 2020
  ident: ref_89
  article-title: Long Non-Coding RNA Paternally Expressed Imprinted Gene 10 (PEG10) Elevates Diffuse Large B-Cell Lymphoma Progression by Regulating Kinesin Family Member 2A (KIF2A) via Targeting MiR-101-3p
  publication-title: Med. Sci. Monit.
  doi: 10.12659/MSM.922810
  contributor:
    fullname: Zhao
– ident: ref_154
  doi: 10.3390/ncrna7010001
– volume: 10
  start-page: 9637
  year: 2020
  ident: ref_126
  article-title: The value of circulating microRNAs for early diagnosis of B-cell lymphoma: A case-control study on historical samples
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-66062-1
  contributor:
    fullname: Paulsen
– volume: 131
  start-page: 1920
  year: 2018
  ident: ref_43
  article-title: Epigenetic silencing of miR-125b is required for normal B-cell development
  publication-title: Blood
  doi: 10.1182/blood-2018-01-824540
  contributor:
    fullname: Li
– volume: 12
  start-page: 2119
  year: 2020
  ident: ref_140
  article-title: LncRNA MORT Inhibits Cancer Cell Proliferation and Promotes Apoptosis in Mantle Cell Lymphoma by Upregulating miRNA-16
  publication-title: Cancer Manag. Res.
  doi: 10.2147/CMAR.S233859
  contributor:
    fullname: Tang
– volume: 45
  start-page: 469
  year: 2021
  ident: ref_93
  article-title: lncRNA FOXP4-AS1 predicts poor prognosis and accelerates the progression of mantle cell lymphoma through the miR-423-5p/NACC1 pathway
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2020.7897
  contributor:
    fullname: Tao
– ident: ref_123
  doi: 10.1371/journal.pone.0016408
– volume: 117
  start-page: 6227
  year: 2011
  ident: ref_53
  article-title: Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1
  publication-title: Blood
  doi: 10.1182/blood-2010-10-312231
  contributor:
    fullname: Craig
– volume: 4
  start-page: 38
  year: 2017
  ident: ref_22
  article-title: Circular RNAs: Biogenesis, function and role in human diseases
  publication-title: Front. Mol. Biosci.
  doi: 10.3389/fmolb.2017.00038
  contributor:
    fullname: Greene
– volume: 11
  start-page: 423
  year: 2016
  ident: ref_124
  article-title: Circulating microRNA-125b and microRNA-130a expression profiles predict chemoresistance to R-CHOP in diffuse large B-cell lymphoma patients
  publication-title: Oncol. Lett.
  doi: 10.3892/ol.2015.3866
  contributor:
    fullname: Yuan
– volume: 21
  start-page: 305
  year: 2021
  ident: ref_101
  article-title: The regulation of miR-320a/XBP1 axis through LINC00963 for endoplasmic reticulum stress and autophagy in diffuse large B-cell lymphoma
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-021-01992-y
  contributor:
    fullname: Cui
– ident: ref_157
– ident: ref_14
  doi: 10.1007/978-1-4939-3378-5
– volume: 29
  start-page: 2015
  year: 2015
  ident: ref_74
  article-title: p53-dependent non-coding RNA networks in chronic lymphocytic leukemia
  publication-title: Leukemia
  doi: 10.1038/leu.2015.119
  contributor:
    fullname: Blume
– volume: 146
  start-page: 353
  year: 2011
  ident: ref_16
  article-title: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language?
  publication-title: Cell
  doi: 10.1016/j.cell.2011.07.014
  contributor:
    fullname: Salmena
– volume: 7
  start-page: 2391
  year: 2016
  ident: ref_38
  article-title: Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.6165
  contributor:
    fullname: Kluiver
– volume: 305
  start-page: 59
  year: 2011
  ident: ref_58
  article-title: Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia
  publication-title: JAMA
  doi: 10.1001/jama.2010.1919
  contributor:
    fullname: Fabbri
– volume: 15
  start-page: 39
  year: 2016
  ident: ref_147
  article-title: Circulating long non-coding RNAs in cancer: Current status and future perspectives
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-016-0524-4
  contributor:
    fullname: Qi
– volume: 24
  start-page: 415
  year: 2016
  ident: ref_37
  article-title: MicroRNA-155 downregulation promotes cell cycle arrest and apoptosis in diffuse large B-cell lymphoma
  publication-title: Oncol. Res. Featur. Preclin. Clin. Cancer Ther.
  contributor:
    fullname: Zhu
– volume: 23
  start-page: 7395
  year: 2019
  ident: ref_105
  article-title: Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p/PIM1 axis
  publication-title: J. Cell. Mol. Med.
  doi: 10.1111/jcmm.14601
  contributor:
    fullname: Zhu
– volume: 92
  start-page: 407
  year: 2014
  ident: ref_118
  article-title: Clinical significance and detection of microRNA-21 in serum of patients with diffuse large B-cell lymphoma in Chinese population
  publication-title: Eur. J. Haematol.
  doi: 10.1111/ejh.12263
  contributor:
    fullname: Chen
– volume: 50
  start-page: 369
  year: 2016
  ident: ref_81
  article-title: Long Non-coding RNA HOTAIR Expression in Diffuse Large B-Cell Lymphoma: In Relation to Polycomb Repressive Complex Pathway Proteins and H3K27 Trimethylation
  publication-title: J. Pathol. Transl. Med.
  doi: 10.4132/jptm.2016.06.06
  contributor:
    fullname: Oh
– volume: 116
  start-page: 281
  year: 2004
  ident: ref_7
  article-title: MicroRNAs: Genomics, biogenesis, mechanism, and function
  publication-title: Cell
  doi: 10.1016/S0092-8674(04)00045-5
  contributor:
    fullname: Bartel
– volume: 32
  start-page: 236
  year: 2001
  ident: ref_25
  article-title: Localisation of a novel region of recurrent amplification in follicular lymphoma to an∼6.8 Mb region of 13q32-33
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/gcc.1187
  contributor:
    fullname: Neat
– volume: 23
  start-page: 2806
  year: 2009
  ident: ref_30
  article-title: Genetic dissection of the miR-17∼92 cluster of microRNAs in Myc-induced B-cell lymphomas
  publication-title: Genes Dev.
  doi: 10.1101/gad.1872909
  contributor:
    fullname: Mu
– volume: 115
  start-page: 104451
  year: 2020
  ident: ref_129
  article-title: FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway
  publication-title: Exp. Mol. Pathol.
  doi: 10.1016/j.yexmp.2020.104451
  contributor:
    fullname: Meng
– volume: 2016
  start-page: 9085195
  year: 2016
  ident: ref_109
  article-title: Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics
  publication-title: Dis. Markers
  doi: 10.1155/2016/9085195
  contributor:
    fullname: Shi
– volume: 467
  start-page: 86
  year: 2010
  ident: ref_47
  article-title: OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
  publication-title: Nature
  doi: 10.1038/nature09284
  contributor:
    fullname: Medina
– volume: 96
  start-page: 33
  year: 2017
  ident: ref_127
  article-title: Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL—another piece in the puzzle
  publication-title: Ann. Hematol.
  doi: 10.1007/s00277-016-2840-6
  contributor:
    fullname: Filip
– volume: 9
  start-page: 402
  year: 2018
  ident: ref_6
  article-title: Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
  publication-title: Front. Endocrinol.
  doi: 10.3389/fendo.2018.00402
  contributor:
    fullname: Hayder
– volume: 109
  start-page: 20047
  year: 2012
  ident: ref_39
  article-title: miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eµ-miR-155 transgenic mouse model
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1213764109
  contributor:
    fullname: Sandhu
– volume: 13
  start-page: 571
  year: 2021
  ident: ref_96
  article-title: LncRNA SBF2-AS1 Promotes Diffuse Large B-Cell Lymphoma Growth by Regulating FGFR2 via Sponging miR-494-3p
  publication-title: Cancer Manag. Res.
  doi: 10.2147/CMAR.S284258
  contributor:
    fullname: Fu
– volume: 42
  start-page: 733
  year: 2021
  ident: ref_95
  article-title: LINC00857 contributes to proliferation and lymphomagenesis by regulating miR-370-3p/CBX3 axis in diffuse large B-cell lymphoma
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgab013
  contributor:
    fullname: Huang
– volume: 18
  start-page: 388
  year: 2019
  ident: ref_20
  article-title: Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression
  publication-title: Mol. Ther. Nucleic Acids
  doi: 10.1016/j.omtn.2019.09.005
  contributor:
    fullname: Liao
– volume: 130
  start-page: 1800
  year: 2017
  ident: ref_4
  article-title: Outcomes in refractory diffuse large B-cell lymphoma: Results from the international SCHOLAR-1 study
  publication-title: Blood
  doi: 10.1182/blood-2017-03-769620
  contributor:
    fullname: Crump
– volume: 120
  start-page: 1678
  year: 2012
  ident: ref_33
  article-title: LNA-mediated anti–miR-155 silencing in low-grade B-cell lymphomas
  publication-title: Blood J. Am. Soc. Hematol.
  contributor:
    fullname: Zhang
– volume: 17
  start-page: 2712
  year: 2011
  ident: ref_52
  article-title: miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-10-3244
  contributor:
    fullname: Zauli
– ident: ref_160
– volume: 158
  start-page: 593
  year: 2014
  ident: ref_85
  article-title: Genome-wide Mapping and Characterization of Notch-Regulated Long Noncoding RNAs in Acute Leukemia
  publication-title: Cell
  doi: 10.1016/j.cell.2014.05.049
  contributor:
    fullname: Trimarchi
– volume: 431
  start-page: 255
  year: 2014
  ident: ref_141
  article-title: Investigation of circulating lncRNAs in B-cell neoplasms
  publication-title: Clin. Chim. Acta
  doi: 10.1016/j.cca.2014.02.010
  contributor:
    fullname: Isin
– ident: ref_15
  doi: 10.3390/cells8091015
– volume: 22
  start-page: 583
  year: 2010
  ident: ref_42
  article-title: MicroRNA 125b inhibition of B cell differentiation in germinal centers
  publication-title: Int. Immunol.
  doi: 10.1093/intimm/dxq042
  contributor:
    fullname: Gururajan
– volume: 16
  start-page: 177
  year: 2016
  ident: ref_128
  article-title: Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity
  publication-title: Clin. Exp. Med.
  doi: 10.1007/s10238-015-0350-9
  contributor:
    fullname: Peng
– volume: 28
  start-page: 2376
  year: 2014
  ident: ref_82
  article-title: FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma
  publication-title: Leukemia
  doi: 10.1038/leu.2014.126
  contributor:
    fullname: Sehgal
– volume: 40
  start-page: 172
  year: 2019
  ident: ref_107
  article-title: Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis
  publication-title: Trends Pharmacol. Sci.
  doi: 10.1016/j.tips.2019.01.006
  contributor:
    fullname: Bebawy
– ident: ref_159
– volume: 231
  start-page: 116335
  year: 2019
  ident: ref_92
  article-title: LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2019.03.040
  contributor:
    fullname: Wang
– volume: 10
  start-page: 731
  year: 2019
  ident: ref_103
  article-title: LncRNA SNHG14/miR-5590-3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1/PD-L1 checkpoint
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-019-1886-5
  contributor:
    fullname: Zhao
– volume: 107
  start-page: 3111
  year: 2010
  ident: ref_41
  article-title: Targeting of SMAD5 links microRNA-155 to the TGF-β pathway and lymphomagenesis
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0910667107
  contributor:
    fullname: Rai
– volume: 435
  start-page: 828
  year: 2005
  ident: ref_28
  article-title: A microRNA polycistron as a potential human oncogene
  publication-title: Nature
  doi: 10.1038/nature03552
  contributor:
    fullname: He
– volume: 6
  start-page: 27842
  year: 2016
  ident: ref_136
  article-title: A potential panel of six-long non-coding RNA signature to improve survival prediction of diffuse large-B-cell lymphoma
  publication-title: Sci. Rep.
  doi: 10.1038/srep27842
  contributor:
    fullname: Sun
– volume: 9
  start-page: 34644
  year: 2018
  ident: ref_119
  article-title: Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.26141
  contributor:
    fullname: Cui
– volume: 18
  start-page: 2443
  year: 2019
  ident: ref_149
  article-title: Overexpression of lncRNA GATA6-AS inhibits cancer cell proliferation in mantle cell lymphoma by downregulating GLUT1
  publication-title: Oncol. Lett.
  contributor:
    fullname: Fan
– volume: 23
  start-page: 157
  year: 2018
  ident: ref_133
  article-title: Aberrant NEAT1_1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma
  publication-title: Cancer Biomark.
  doi: 10.3233/CBM-160221
  contributor:
    fullname: Deng
– volume: 10
  start-page: 13
  year: 2018
  ident: ref_152
  article-title: Circulating MicroRNAs as Biomarkers in Diffuse Large B-cell Lymphoma: A Pilot Prospective Longitudinal Clinical Study
  publication-title: Biomark. Cancer
  doi: 10.1177/1179299X18781095
  contributor:
    fullname: Bouvy
– ident: ref_10
  doi: 10.3390/ncrna5010017
– volume: 104
  start-page: 7080
  year: 2007
  ident: ref_61
  article-title: miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0702409104
  contributor:
    fullname: Zhou
– volume: 141
  start-page: 672
  year: 2008
  ident: ref_110
  article-title: Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
  publication-title: Br. J. Haematol.
  doi: 10.1111/j.1365-2141.2008.07077.x
  contributor:
    fullname: Lawrie
– volume: 27
  start-page: 847
  year: 2007
  ident: ref_34
  article-title: microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2007.10.009
  contributor:
    fullname: Vigorito
– volume: 79
  start-page: 188
  year: 2016
  ident: ref_76
  article-title: Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2016.02.032
  contributor:
    fullname: Peng
– volume: 11
  start-page: 2095
  year: 2021
  ident: ref_135
  article-title: Circulating long non-coding RNAs HOTAIR, Linc-p21, GAS5 and XIST expression profiles in diffuse large B-cell lymphoma: Association with R-CHOP responsiveness
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-021-81715-5
  contributor:
    fullname: Senousy
– volume: 34
  start-page: 2105
  year: 2014
  ident: ref_144
  article-title: MicroRNA signatures in subtypes of follicular lymphoma
  publication-title: Anticancer Res.
  contributor:
    fullname: Gebauer
– volume: 7
  start-page: 612393
  year: 2020
  ident: ref_163
  article-title: Long Non-coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy
  publication-title: Front. Med.
  doi: 10.3389/fmed.2020.612393
  contributor:
    fullname: Qian
– volume: 14
  start-page: 468
  year: 2014
  ident: ref_155
  article-title: Role of GAS5 Noncoding RNA in Mediating the Effects of Rapamycin and Its Analogues on Mantle Cell Lymphoma Cells
  publication-title: Clin. Lymphoma Myeloma Leuk.
  doi: 10.1016/j.clml.2014.02.011
  contributor:
    fullname: Williams
– volume: 38
  start-page: 1363
  year: 2017
  ident: ref_130
  article-title: Microarray expression profiles of long non-coding RNAs in germinal center-like diffuse large B-cell lymphoma
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2017.5821
  contributor:
    fullname: Gao
– volume: 22
  start-page: 3929
  year: 2018
  ident: ref_19
  article-title: LncRNA MALAT1/miR-129 axis promotes glioma tumorigenesis by targeting SOX2
  publication-title: J. Cell. Mol. Med.
  doi: 10.1111/jcmm.13667
  contributor:
    fullname: Xiong
– volume: 113
  start-page: 4586
  year: 2009
  ident: ref_45
  article-title: Patterns of microRNA expression characterize stages of human B-cell differentiation
  publication-title: Blood
  doi: 10.1182/blood-2008-09-178186
  contributor:
    fullname: Zhang
– volume: 206
  start-page: 2803
  year: 2021
  ident: ref_46
  article-title: Context-Dependent miR-21 Regulation of TLR7-Mediated Autoimmune and Foreign Antigen–Driven Antibody-Forming Cell and Germinal Center Responses
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.2001039
  contributor:
    fullname: Schell
– volume: 9
  start-page: 405
  year: 2008
  ident: ref_29
  article-title: Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes
  publication-title: Nat. Immunol.
  doi: 10.1038/ni1575
  contributor:
    fullname: Xiao
– volume: 32
  start-page: 2377
  year: 2013
  ident: ref_31
  article-title: MicroRNA-17∼92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways
  publication-title: EMBO J.
  doi: 10.1038/emboj.2013.178
  contributor:
    fullname: Jin
– volume: 288
  start-page: 1439
  year: 2000
  ident: ref_73
  article-title: Regulation of B lymphocyte and macrophage development by graded expression of PU. 1
  publication-title: Science
  doi: 10.1126/science.288.5470.1439
  contributor:
    fullname: DeKoter
– ident: ref_66
  doi: 10.1371/journal.pone.0138236
– volume: 8
  start-page: 72182
  year: 2017
  ident: ref_75
  article-title: Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK/ERK signaling pathway
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.20053
  contributor:
    fullname: Wang
– volume: 5
  start-page: 185
  year: 2020
  ident: ref_153
  article-title: miRNA signature associated with R–CHOP refractoriness in patients diagnosed with diffuse large B cell lymphoma
  publication-title: Non-Coding RNA Res.
  doi: 10.1016/j.ncrna.2020.10.001
  contributor:
    fullname: Villela
– volume: 184
  start-page: 373
  year: 2019
  ident: ref_138
  article-title: Differential expression of long non-coding RNAs are related to proliferation and histological diversity in follicular lymphomas
  publication-title: Br. J. Haematol.
  doi: 10.1111/bjh.15656
  contributor:
    fullname: Roisman
– volume: 41
  start-page: 377
  year: 2019
  ident: ref_63
  article-title: miR-101 regulates the cell proliferation and apoptosis in diffuse large B-cell lymphoma by targeting MEK1 via regulation of the ERK/MAPK signaling pathway
  publication-title: Oncol. Rep.
  contributor:
    fullname: Huang
– volume: 93
  start-page: 1735
  year: 2014
  ident: ref_122
  article-title: Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients
  publication-title: Ann. Hematol.
  doi: 10.1007/s00277-014-2111-3
  contributor:
    fullname: Song
– volume: 37
  start-page: 95
  year: 2018
  ident: ref_121
  article-title: Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: An explorative pilot study
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/s13046-018-0768-5
  contributor:
    fullname: Marchesi
– volume: 21
  start-page: 298
  year: 1998
  ident: ref_26
  article-title: Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/(SICI)1098-2264(199804)21:4<298::AID-GCC3>3.0.CO;2-U
  contributor:
    fullname: Monni
– volume: 510
  start-page: 594
  year: 2019
  ident: ref_77
  article-title: LncRNA FIRRE is activated by MYC and promotes the development of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2019.01.105
  contributor:
    fullname: Shi
– volume: 92
  start-page: 234
  year: 1998
  ident: ref_27
  article-title: Chromosomal and Gene Amplification in Diffuse Large B-Cell Lymphoma
  publication-title: Blood
  doi: 10.1182/blood.V92.1.234.413k22_234_240
  contributor:
    fullname: Rao
– volume: 211
  start-page: 2183
  year: 2014
  ident: ref_32
  article-title: The miR-155–PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20140338
  contributor:
    fullname: Lu
– ident: ref_162
– volume: 577
  start-page: 132
  year: 2016
  ident: ref_137
  article-title: A pilot study of long noncoding RNA expression profiling by microarray in follicular lymphoma
  publication-title: Gene
  doi: 10.1016/j.gene.2015.11.029
  contributor:
    fullname: Pan
– ident: ref_8
  doi: 10.3390/cells9020276
– volume: 186
  start-page: 2462
  year: 2016
  ident: ref_64
  article-title: Long noncoding RNA expression profiling in normal B-cell subsets and Hodgkin lymphoma reveals hodgkin and reed-sternberg cell–specific long noncoding RNAs
  publication-title: Am. J. Pathol.
  doi: 10.1016/j.ajpath.2016.05.011
  contributor:
    fullname: Tayari
– volume: 2021
  start-page: 5593720
  year: 2021
  ident: ref_98
  article-title: TUC338 Promotes Diffuse Large B Cell Lymphoma Growth via Regulating EGFR/PI3K/AKT Signaling Pathway
  publication-title: J. Oncol.
  contributor:
    fullname: Li
– ident: ref_148
  doi: 10.3390/cells10010048
– volume: 95
  start-page: 11
  year: 2016
  ident: ref_151
  article-title: Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: A systematic review
  publication-title: Ann. Hematol.
  doi: 10.1007/s00277-015-2553-2
  contributor:
    fullname: Adams
– volume: 29
  start-page: 452
  year: 2016
  ident: ref_11
  article-title: Long noncoding RNAs in cancer pathways
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.03.010
  contributor:
    fullname: Schmitt
– volume: 13
  start-page: 3589
  year: 2021
  ident: ref_99
  article-title: LINC00908 Promotes Diffuse Large B-Cell Lymphoma Development by Down-Regulating miR-671-5p
  publication-title: Cancer Manag. Res.
  doi: 10.2147/CMAR.S299715
  contributor:
    fullname: Zeng
– volume: 44
  start-page: 1331
  year: 2020
  ident: ref_78
  article-title: Long non-coding RNA DBH-AS1 promotes cancer progression in diffuse large B-cell lymphoma by targeting FN1 via RNA-binding protein BUD13
  publication-title: Cell Biol. Int.
  doi: 10.1002/cbin.11327
  contributor:
    fullname: Song
– volume: 124
  start-page: 2988
  year: 2014
  ident: ref_115
  article-title: Availability of Circulating microRNAs as a Biomarker for the Early Diagnosis of Diffuse Large B-Cell Lymphoma
  publication-title: Blood
  doi: 10.1182/blood.V124.21.2988.2988
  contributor:
    fullname: Inada
– volume: 22
  start-page: 1775
  year: 2012
  ident: ref_13
  article-title: The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression
  publication-title: Genome Res.
  doi: 10.1101/gr.132159.111
  contributor:
    fullname: Derrien
– volume: 161
  start-page: 319
  year: 2015
  ident: ref_87
  article-title: The BRAF Pseudogene Functions as a Competitive Endogenous RNA and Induces Lymphoma In Vivo
  publication-title: Cell
  doi: 10.1016/j.cell.2015.02.043
  contributor:
    fullname: Florian
– volume: 144
  start-page: 102825
  year: 2019
  ident: ref_9
  article-title: The opportunistic effect of exosomes on Non-Hodgkin Lymphoma microenvironment modulation
  publication-title: Crit. Rev. Oncol. Hematol.
  doi: 10.1016/j.critrevonc.2019.102825
  contributor:
    fullname: Fernandes
– volume: 16
  start-page: 16
  year: 2017
  ident: ref_131
  article-title: Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-017-0580-4
  contributor:
    fullname: Zhou
– volume: 89
  start-page: 939
  year: 2017
  ident: ref_84
  article-title: The effects of the long non-coding RNA MALAT-1 regulated autophagy-related signaling pathway on chemotherapy resistance in diffuse large B-cell lymphoma
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2017.02.011
  contributor:
    fullname: Li
– volume: 9
  start-page: 17161
  year: 2019
  ident: ref_116
  article-title: Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-52985-x
  contributor:
    fullname: Beheshti
– volume: 642
  start-page: 205
  year: 2018
  ident: ref_125
  article-title: Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions
  publication-title: Gene
  doi: 10.1016/j.gene.2017.11.022
  contributor:
    fullname: Meng
– volume: 1
  start-page: 288
  year: 2009
  ident: ref_40
  article-title: Onco-miR-155 targets SHIP1 to promote TNFα-dependent growth of B cell lymphomas
  publication-title: EMBO Mol. Med.
  doi: 10.1002/emmm.200900028
  contributor:
    fullname: Pedersen
– ident: ref_71
  doi: 10.1371/journal.pgen.1007050
– ident: ref_2
  doi: 10.3390/ijms21062081
– volume: 15
  start-page: 7
  year: 2014
  ident: ref_21
  article-title: Long non-coding RNAs: New players in cell differentiation and development
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg3606
  contributor:
    fullname: Fatica
– ident: ref_104
  doi: 10.1080/10428194.2021.1876866
– volume: 31
  start-page: 3002
  year: 2012
  ident: ref_59
  article-title: Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas
  publication-title: Oncogene
  doi: 10.1038/onc.2011.470
  contributor:
    fullname: Zhang
– volume: 172
  start-page: 393
  year: 2018
  ident: ref_12
  article-title: Functional Classification and Experimental Dissection of Long Noncoding RNAs
  publication-title: Cell
  doi: 10.1016/j.cell.2018.01.011
  contributor:
    fullname: Kopp
– volume: 97
  start-page: 223
  year: 2013
  ident: ref_50
  article-title: MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen
  publication-title: Int. J. Hematol.
  doi: 10.1007/s12185-012-1256-x
  contributor:
    fullname: Bai
– volume: 102
  start-page: 13944
  year: 2005
  ident: ref_57
  article-title: miR-15 and miR-16 induce apoptosis by targeting BCL2
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0506654102
  contributor:
    fullname: Cimmino
– ident: ref_164
– volume: 17
  start-page: 1
  year: 2017
  ident: ref_150
  article-title: LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy
  publication-title: Clin. Exp. Med.
  doi: 10.1007/s10238-015-0396-8
  contributor:
    fullname: Peng
– volume: 24
  start-page: 50
  year: 2019
  ident: ref_17
  article-title: Long non-coding RNA Malat1 activated autophagy, hence promoting cell proliferation and inhibiting apoptosis by sponging miR-101 in colorectal cancer
  publication-title: Cell. Mol. Biol. Lett.
  doi: 10.1186/s11658-019-0175-8
  contributor:
    fullname: Si
– volume: 25
  start-page: 1849
  year: 2011
  ident: ref_44
  article-title: Eμ/miR-125b transgenic mice develop lethal B-cell malignancies
  publication-title: Leukemia
  doi: 10.1038/leu.2011.166
  contributor:
    fullname: Enomoto
– volume: 28
  start-page: 451
  year: 2014
  ident: ref_56
  article-title: The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: Implications for therapy in p53-defective CLL patients
  publication-title: Leukemia
  doi: 10.1038/leu.2013.298
  contributor:
    fullname: Boysen
– volume: 461
  start-page: 47
  year: 2019
  ident: ref_79
  article-title: Downregulation of long non-coding RNA TUG1 suppresses tumor growth by promoting ubiquitination of MET in diffuse large B-cell lymphoma
  publication-title: Mol. Cell. Biochem.
  doi: 10.1007/s11010-019-03588-7
  contributor:
    fullname: Cheng
– volume: 11
  start-page: 650287
  year: 2021
  ident: ref_106
  article-title: LncRNA SNHG8 Promotes Proliferation and Inhibits Apoptosis of Diffuse Large B-Cell Lymphoma via Sponging miR-335-5p
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2021.650287
  contributor:
    fullname: Yu
– volume: 7
  start-page: 110
  year: 2015
  ident: ref_146
  article-title: Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphoma
  publication-title: Genome Med.
  doi: 10.1186/s13073-015-0230-7
  contributor:
    fullname: Verma
– volume: 16
  start-page: 419
  year: 2016
  ident: ref_24
  article-title: A c-Myc/miR17-92/Pten Axis Controls PI3K-Mediated Positive and Negative Selection in B Cell Development and Reconstitutes CD19 Deficiency
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2016.05.084
  contributor:
    fullname: Benhamou
– ident: ref_158
– volume: 128
  start-page: e10
  year: 2016
  ident: ref_65
  article-title: Long noncoding RNAs in B-cell development and activation
  publication-title: Blood J. Am. Soc. Hematol.
  contributor:
    fullname: Johnson
– volume: 25
  start-page: 2567
  year: 2021
  ident: ref_90
  article-title: LncRNA PCAT1 enhances cell proliferation, migration and invasion by miR-508-3p/NFIB axis in diffuse large B-cell lymphoma
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
  contributor:
    fullname: Tian
– volume: 70
  start-page: 45
  year: 2018
  ident: ref_113
  article-title: Over expression of circulating miR-155 predicts prognosis in diffuse large B-cell lymphoma
  publication-title: Leuk. Res.
  doi: 10.1016/j.leukres.2018.05.006
  contributor:
    fullname: Ahmadvand
– volume: 15
  start-page: 246
  year: 2021
  ident: ref_114
  article-title: A novel prognostic model based on four circulating miRNA in diffuse large B-cell lymphoma: Implications for the roles of MDSC and Th17 cells in lymphoma progression
  publication-title: Mol. Oncol.
  doi: 10.1002/1878-0261.12834
  contributor:
    fullname: Sun
– volume: 214
  start-page: 1462
  year: 2018
  ident: ref_134
  article-title: Long non-coding RNAs expression levels in diffuse large B-cell lymphoma: An in silico analysis
  publication-title: Pathol. Res. Pract.
  doi: 10.1016/j.prp.2018.08.006
  contributor:
    fullname: Dousti
– volume: 132
  start-page: 2389
  year: 2018
  ident: ref_62
  article-title: miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels
  publication-title: Blood
  doi: 10.1182/blood-2018-06-855502
  contributor:
    fullname: Musilova
– volume: 14
  start-page: 346
  year: 2016
  ident: ref_83
  article-title: LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
  publication-title: J. Transl. Med.
  doi: 10.1186/s12967-016-1100-9
  contributor:
    fullname: Wang
– ident: ref_117
  doi: 10.1371/journal.pone.0187722
– volume: 492
  start-page: 480
  year: 2017
  ident: ref_18
  article-title: Malat1 activates autophagy and promotes cell proliferation by sponging miR-101 and upregulating STMN1, RAB5A and ATG4D expression in glioma
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2017.08.070
  contributor:
    fullname: Fu
– volume: 99
  start-page: 15524
  year: 2002
  ident: ref_5
  article-title: Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.242606799
  contributor:
    fullname: Calin
– volume: 8
  start-page: 34374
  year: 2017
  ident: ref_132
  article-title: The long non-coding RNA NONHSAG026900 predicts prognosis as a favorable biomarker in patients with diffuse large B-cell lymphoma
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.16163
  contributor:
    fullname: Zhao
– volume: 118
  start-page: 5550
  year: 2011
  ident: ref_143
  article-title: MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype
  publication-title: Blood
  doi: 10.1182/blood-2011-06-361972
  contributor:
    fullname: Leich
SSID ssj0000913814
Score 2.2241008
SecondaryResourceType review_article
Snippet Non-Hodgkin lymphoma (NHL) is a heterogeneous malignancy with variable patient outcomes. There is still a lack of understanding about the different players...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1934
SubjectTerms B-cell lymphoma
Biomarkers
Biopsy
Cell cycle
Cell growth
Chemotherapy
Gene expression
lncRNAs
Lymphocytes B
Lymphoma
Malignancy
Medical prognosis
MicroRNAs
miRNA
miRNAs
Molecular modelling
Non-coding RNA
Non-Hodgkin's lymphoma
Pathogenesis
Patients
Review
Transcription factors
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT3CoKI-StiAjcSRqHnZic1uqVguCFUJU6i2yPTGs2jpVd3vosf-cGTtddlElLtwsPyJ7Zmx_E48_M_bOFcoW3svcW4RvAkSRG4TFeeGUcqY0jdZ0d_jrrJmeis9n8mztqS-KCUv0wElwhxKEd6CVML0QAMoUkcLNa9yYPIjEBFroNWcqrsG6xK1IJJqhGv36w3SbPZ5WL7At4haxsRVFxv6HYObf0ZJr28_JU7Y94kY-Sf3dYY_68Iw9WWMTfM7ujiIGjsFA_DjAkPhX-ffZhM9StDf_FHA5on8I_HJO-SYAvwiOkvPAZ0PIpwP8PMf0l1vU83BpPvCRwolPUrjAIjYa-UQv-Lc_tzUXL9jpyfGPo2k-vrCQO_R0ljnUOCpPR7oVKChlW8neGCdasMJrbSVKGxpb170svG1VaSpNgKLwREynVP2SbYUh9K8Yt7g0NNagrH2J7YVyUFrtLIBzldEmY-_vhd1dJSKNDh0Q0k33gG4y9pEUsqpKLNgxA22jG22j-5dtZOzgXp3dODUXHXGmtRIdRZWxt6tinFR0UmJCj4qhOhQuhPgoY7tJ-6ueEJ-PwA9krN2wi42ubpaE-a9I3K0arZSQe_9jbPvscUXhNWWVl-0B21pe3_SvER8t7Zs4FX4DC9sSxA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZge4EDKu_QgozEkahO4iQ2l2pbbbUgiKqKSr1FfsRlReuUZjlw5J93xvFuu6jiZjm25Xg842_s8WdCPhgmNHOuTJ0G-MYtZ6kCWJwyI4RRmaqkxLvD35pqfsq_nJVnccNtiGGVK5sYDLXtDe6R7yHVVV0Cvhf7V79SfDUKT1fjExoPyVYOngKbkK2DWXN8st5lQdZLkfGRbqgA_35vvNUeTq0HmYG-FnxjSQrM_ffBzX-jJu8sQ0fb5EnEj3Q6CvwpedD5Z-TxHVbB5-TvYcDCISiIzrztRx5WetJMaTNGfdPPHswS7iXQywXmK2_phTeYXHja9D6d9_b8J6S__gF595fqE41UTnQ6hg0MoVLkFb2gx7e3NocX5PRo9v1wnsaXFlIDHs8ytQX8lcOj3dwKm5V1XnZKGV5bzZ2UulSssJUuiq5kTtciU7lEYMEcEtQJUbwkE9_77jWhGkxEpRWMtcugPhfGZloaba0xuZIqIR9Xg91ejYQaLTgiKJv2Htkk5AAFsi6KbNgho78-b6NytaXlzlgpuOo4t1YoFmj-HLTBneXQyO5KnG1U0aG9nVAJeb_-DMqFJybKdyAYLINhQ4CTEvJqlP66J8jrw6GBhNQb82Kjq5tf_OJHIPAWlRSCl2_-360d8ijHAJosT7N6l0yW17-7t4CAlvpdnOY3tHgLeg
  priority: 102
  providerName: ProQuest
Title Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives
URI https://www.ncbi.nlm.nih.gov/pubmed/34944752
https://www.proquest.com/docview/2612752878
https://search.proquest.com/docview/2614237008
https://pubmed.ncbi.nlm.nih.gov/PMC8698845
https://doaj.org/article/5d4fcd984ae44dd8a039371f9124fd44
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB615QIHxJuUEhmJI9vsw961uaVRqoDoKqqo1NvKj3WJSLxVkx448s8Ze3dDgnriZnlty-sZ2zP2N58BPuqYq9haFlmF5hs1NI4kmsVRrDnXMpG5ED52-KLMZ1f06zW7PgDWx8IE0L5Wi1O3XJ26xY-Arbxd6VGPExvNLyY8F5xTNjqEQ1TQHRc9LL8iwV2ItgxDGbr0ozaQPVxUr0WCUzTzr_F4XhZasHRvQwq8_Q8Zm_9iJnc2ofNn8LSzHsm47eVzOKjdC3iywyn4En5PgiUcIEFk6kzTsrCSy3JMyhbzTb44XJT8SQJZLXy-dIYsnfbJhSNl46JZY25-YvrbL5R2s5KfSUfkRMYtaGAdKnWsoksy_xuzuX4FV-fT75NZ1L2zEGn0dzaRyfCvrL_YTQ03CStSVkupaWEUtUIoJuPM5CrLahZbVfBEpsKbFbH19HScZ6_hyDWufgtE4QKRK4nDbhOsT7k2iRJaGaN1KoUcwKd-sKvblk6jQjfEi6l6QEwDOPMC2Rb1XNgho7m7qTqNqJihVhvBqawpNYbLOJD8WWyDWkOxkZNenFU3QdeVZ05D4fOCD-DD9jNOLX9fIl2NgvFlPGgIraQBvGmlv-1Jrz0DKPb0Yq-r-19QmwN9d6e9x_9d8x08Tj2yJkmjpDiBo83dff0eTaONGsKjs2k5vxyGo4VhmBh_AN3pFbw
link.rule.ids 230,315,730,783,787,867,888,2109,21400,27936,27937,33756,33757,43817,53804,53806,74630
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwELZaOLQ9VH3SFEpdqcdGxImT2L2gBS1a2iVCCCRukR8xXRUcSraHHvvPO5N4Fxah3izHthyPZ_yNPf5MyGeTCJ04l8dOA3zjliexAlgcJ0YIo5gqpMS7w0dVMTnj387z87Dh1oWwyoVN7A21bQ3uke8g1VWZA74Xu9e_Ynw1Ck9XwxMaj8k6UlWB87W-N66OT5a7LMh6KRgf6IYy8O93hlvt_al1Jxnoa8ZXlqSeuf8huHk_avLOMnTwgjwP-JGOBoG_JI8a_4o8u8Mq-Jr83e-xcB8URMfetgMPKz2pRrQaor7poQezhHsJ9GqG-cpbeukNJmeeVq2PJ629-Anp6R-Qd3ulvtJA5URHQ9hA11cKvKKX9Pj21mb3hpwdjE_3J3F4aSE24PHMY5vBXzk82k2tsCwv07xRyvDSau6k1LlKMlvoLGvyxOlSMJVKBBaJQ4I6IbK3ZM23vnlHqAYTUWgFY-0Y1OfCWKal0dYakyqpIvJlMdj19UCoUYMjgrKpH5BNRPZQIMuiyIbdZ7Q3F3VQrjq33BkrBVcN59YKlfQ0fw7a4M5yaGRrIc46qGhX306oiHxafgblwhMT5RsQDJbBsCHASRHZGKS_7Any-nBoICLlyrxY6erqFz_70RN4i0IKwfP3_-_WR_Jkcno0raeH1fdN8jTFYBqWxqzcImvzm9_NB0BDc70dpvw_jWAOdA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLagkxA8IO4EBhiJR6LGiZPYvKButOpgRNXEpL1FvsSjYnPGUh545J9zTuJ2K5p4sxzbcnx8-ezz-TMh70widOJcHjsN8I1bnsQKYHGcGCGMYqqQEu8Of62K-TH_fJKfBP5TF2iV6zmxn6hta_CMfIxSV2UO-F6MXaBFLD7NPl78jPEFKfS0huc0bpOdkhdZMiI7e9NqcbQ5cUEFTMH4ID2UwV5_PNxw7z3YnWQwdjO-tTz1Kv43Qc9_GZTXlqTZA3I_YEk6GYz_kNxq_CNy75rC4GPyZ7_HxT1BiE69bQdNVnpUTWg1MMDpgYcpCs8V6PkS45W39MwbDC49rVofz1t7-gPCh7_B9u25-kCDrBOdDBSCrs8UNEbP6OLqBmf3hBzPpt_253F4dSE2sPtZxTaDv3Lo5k2tsCwv07xRyvDSau6k1LlKMlvoLGvyxOlSMJVKBBmJQ7E6IbKnZORb3zwnVMN0UWgFbe0Y5OfCWKal0dYakyqpIvJ-3dj1xSCuUcOmBG1T32CbiOyhQTZJURm7j2gvT-sw0OrccmesFFw1nFsrVNJL_jkogzvLoZDdtTnrMFy7-qpzReTt5jMMNPSeKN-AYTANUogAM0Xk2WD9TU1Q44dDAREpt_rFVlW3v_jl917MWxRSCJ6_-H-13pA70Nvrw4Pqy0tyN0VeDUtjVu6S0eryV_MKgNFKvw49_i_jRBKi
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Competitive+Endogenous+RNA+Network+Involving+miRNA+and+lncRNA+in+Non-Hodgkin+Lymphoma%3A+Current+Advances+and+Clinical+Perspectives&rft.jtitle=Biomedicines&rft.au=Fernandes%2C+Mara&rft.au=Marques%2C+Herlander&rft.au=Teixeira%2C+Ana+Lu%C3%ADsa&rft.au=Medeiros%2C+Rui&rft.date=2021-12-17&rft.issn=2227-9059&rft.eissn=2227-9059&rft.volume=9&rft.issue=12&rft.spage=1934&rft_id=info:doi/10.3390%2Fbiomedicines9121934&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_biomedicines9121934
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2227-9059&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2227-9059&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2227-9059&client=summon